Your browser doesn't support javascript.
loading
Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis.
Yoshida, Shunsuke; Saito, Tomohiro; Shibagaki, Keigo; Hirao, Keiichi; Yuza, Takatoshi; Tomosugi, Naohisa; Honda, Hirokazu.
Afiliación
  • Yoshida S; Division of Nephrology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Saito T; Division of Nephrology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Shibagaki K; Shibagaki Clinic Jiyugaoka, Tokyo, Japan.
  • Hirao K; Shibagaki Clinic Togoshi, Tokyo, Japan.
  • Yuza T; Shibagaki Clinic Kugahara, Tokyo, Japan.
  • Tomosugi N; Division of Systems Bioscience for Drug Discovery, Medical Research Institute, Kanazawa Medical University, Kanazawa, Japan.
  • Honda H; Division of Nephrology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan. hondah@med.showa-u.ac.jp.
Sci Rep ; 13(1): 3181, 2023 02 23.
Article en En | MEDLINE | ID: mdl-36823243

Texto completo: 1 Colección: 01-internacional Asunto principal: Eritropoyetina / Anemia Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Asunto principal: Eritropoyetina / Anemia Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón